Not surprised. IMO Phase 3 was always expected to receive at least partial funding from PAR shareholders.
- Forums
- ASX - By Stock
- PAR
- Ann: Notice of General Meeting/Proxy Form
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.59%
!
28.3¢

Ann: Notice of General Meeting/Proxy Form, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.3¢ |
Change
-0.008(2.59%) |
Mkt cap ! $110.9M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 28.3¢ | $22.78K | 79.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 309585 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 72707 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 309585 | 0.280 |
7 | 79271 | 0.275 |
7 | 114647 | 0.270 |
1 | 11206 | 0.265 |
5 | 29401 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 72707 | 5 |
0.300 | 19063 | 3 |
0.305 | 2746 | 1 |
0.310 | 161674 | 5 |
0.315 | 68233 | 4 |
Last trade - 12.54pm 17/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online